ArticlePhysical and engineering sciences in medicine2026
Dose monitoring-guided replanning timing in adaptive radiotherapy for laryngeal cancer.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to determine the optimal timing for adaptive replanning in patients with locally advanced laryngeal cancer undergoing radiotherapy and to investigate how this timing varies based on anatomical and dosimetric threshold values. Volumetric modulated arc therapy planning was performed for twenty patients with locally advanced laryngeal cancer. All treatments were delivered with daily two dimensional kilovoltage imaging and weekly three dimensional cone beam computed tomography (CBCT) imaging for patient setup verification. The six weekly CBCT datasets obtained during the treatment course were used for dose accumulation analysis. Weekly dose variations in the target volumes and organs at risk were evaluated according to predefined dosimetric thresholds. Neck diameters and parotid gland volumes were measured on the synthetic computed tomography images generated from CBCTs using deformable image registration and assessed according to anatomical thresholds. An average reduction of - 1.18 ± 0.67 cm in neck diameter was observed throughout the treatment course. When the initial plan was compared with the weekly accumulated doses, a D98% dose deviation of - 1.92 Gy was detected for PTV54, while the mean dose deviations for the ipsilateral and contralateral parotid glands were calculated as 2.10 Gy and 1.46 Gy, respectively. By the end of treatment, approximately 65% of patients had exceeded at least one anatomical or dosimetric threshold. The third week, when these thresholds first began to be exceeded, appears to represent a potential standard reference point for replanning evaluation. In patients with locally advanced laryngeal cancer, the third week of treatment, when anatomical and dosimetric thresholds are generally beginning to be exceeded, may serve as a standard reference point for re-planning assessment in radiotherapy. However, it should be noted that anatomical and dosimetric thresholds are not always exceeded simultaneously, and relying solely on anatomical changes may be insufficient for making accurate replanning decisions.
Indexed as
Identifiers
42423838What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.